Shuichiro Takashima
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 10
- Multiple Myeloma Research and Treatments 4
- Immunology top 10%
- Immune Cell Function and Interaction 6
-
- Cancer Treatment and Pharmacology 4
- Polyomavirus and related diseases 4
- Cancer Cells and Metastasis 4
-
- Clinical Nutrition and Gastroenterology 4
-
- Cytomegalovirus and herpesvirus research 3
- Co-authors
- Koichi AkashiTakanori TeshimaHiromi IwasakiNobuyuki ShimonoShinji ShimodaTokiyoshi AyabeYoshihiro EriguchiKiminori Nakamura
- Cited by
- HematologyImmunologyOncology
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Shuichiro Takashima
24 papers receiving 604 citations
Peers
Comparison fields: 5 of 73
- Hematology 329
- Immunology 221
- Oncology 171
- Microbiology 28
- Transplantation 12
Countries citing papers authored by Shuichiro Takashima
This map shows the geographic impact of Shuichiro Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichiro Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichiro Takashima more than expected).
Fields of papers citing papers by Shuichiro Takashima
This network shows the impact of papers produced by Shuichiro Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichiro Takashima. The network helps show where Shuichiro Takashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuichiro Takashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 22 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2019 | 67 | |
| 7 | 2016 | 13 | |
| 8 | 2016 | 2 | |
| 9 | 2014 | 6 | |
| 10 | 2014 | 6 | |
| 11 | Comparison of bortezomib, cyclophosphamide, and dexamethasone (VCD) induction with bortezomib and dexamethasone (BD) induction for newly diagnosed symptomatic multiple myeloma | 2014 | 1 |
| 12 | 2013 | 15 | |
| 13 | 2013 | 17 | |
| 14 | 2012 | 230 | |
| 15 | 2012 | 4 | |
| 16 | 2012 | 5 | |
| 17 | 2012 | 14 | |
| 18 | 2011 | 108 | |
| 19 | 2010 | 72 | |
| 20 | 2008 | 3 |
About Shuichiro Takashima
Shuichiro Takashima is a scholar working on Hematology, Oncology and Immunology, having authored 24 papers that have together received 610 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (6 papers), Clinical Nutrition and Gastroenterology (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Polyomavirus and related diseases (4 papers), Cancer Cells and Metastasis (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Hematology (329 citations), Immunology (221 citations) and Oncology (171 citations). Shuichiro Takashima has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Koichi Akashi, Takanori Teshima, Hiromi Iwasaki, Nobuyuki Shimono, Shinji Shimoda, Tokiyoshi Ayabe, Yoshihiro Eriguchi, Kiminori Nakamura, Sonoko Shimoji and Hidetaka Uryu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.